Artículos del autor

solaci

Institutional News

SOLACI Renewed Authorities During the SOLACI-CACI 2021 Congress

After a massive event attended by thousands of people, the Latin American Society of Interventional Cardiology renewed...
solaci -
Scientific Articles COVID-19

Heparin Anticoagulation in Critically Ill COVID-19 Patients: Results that Differ from the Rest

In critically ill COVID-19 patients, an initial strategy of anticoagulation with heparin did not result in any...
solaci -
Scientific Articles COVID-19

Surviving Covid-19 with Good Old Heparin?

Patients hospitalized for COVID-19 are at high risk for thrombosis, particularly venous thromboembolism. This information is not...
solaci -
Scientific Articles COVID-19

Anticoagulation with Heparin in Non-Critical COVID-19

In non-severe COVID-19 patients, an initial therapeutic strategy with heparin increases the chance of survival after discharge...
solaci -
Institutional News

18/08 | SOLACI Webinar – Optimal clinical, anatomical and functional evaluation for decision making in the treatment of coronary bifurcation

solaci -
Institutional News

Watch Again our Webinar on Challenges in TAVR: Evidence, Complex Anatomies, Durability

Watch Again our Webinar on "Challenges in TAVR: Evidence, Complex Anatomies, Durability".
solaci -
Chronic Ischemic cardiopathy

How Bad is Malapposition? OCT Findings and Events

Most post-angioplasty findings with optical coherence tomography (OCT) were not associated with clinical adverse events. Exceptions were...
solaci -
Coronary disease

The Long Marathon of Ultrathin vs. 2nd Generation Thin-Strut DES

After 2.5 years of non-stop racing, ultrathin-strut drug-eluting stents (DES) reached the finish line before 2nd generation...
solaci -